Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Shares Outstanding (Diluted Average) (2021 - 2025)

HeartSciences' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 203.07% year-over-year to $2.8 million; the TTM value through Oct 2025 reached $2.8 million, up 203.07%, while the annual FY2025 figure was $938257.0, 166.16% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $2.8 million in Q4 2025 per HSCS's latest filing, up from $1.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $7.4 million in Q1 2023 to a low of $79506.0 in Q2 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $2.3 million, with a median of $1.1 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): plummeted 98.42% in 2023, then skyrocketed 735.25% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $3.3 million in 2021, then skyrocketed by 109.27% to $6.9 million in 2022, then tumbled by 98.42% to $109841.0 in 2023, then surged by 735.25% to $917445.0 in 2024, then soared by 203.07% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for HSCS's Shares Outstanding (Diluted Average) are $2.8 million (Q4 2025), $1.3 million (Q3 2025), and $938257.0 (Q2 2025).